Fairscale Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$960K Sell
3,779
-22
-0.6% -$5.13K 0.57% 30
2026
Q1
$929K Sell
3,801
-19
-0.5% -$4.43K 0.64% 27
2025
Q4
$790K Hold
3,820
0.52% 32
2025
Q3
$708K Hold
3,820
0.49% 36
2025
Q2
$629K Sell
3,820
-557
-13% -$85.6K 0.46% 36
2025
Q1
$726K Sell
4,377
-179
-4% -$28K 0.66% 30
2024
Q4
$659K Sell
4,556
-159
-3% -$24.6K 0.57% 32
2024
Q3
$764K Hold
4,715
0.67% 29
2024
Q2
$712K Buy
+4,715
New +$701K 0.63% 30

Other funds holding JNJ

Fairscale Capital's JNJ Position: Q2 2026 in Review

Fairscale Capital reduced its Johnson & Johnson (JNJ) stake by 0.58% in Q2 2026, selling an estimated $5.13K and leaving 3,779 shares worth $960K. The position accounts for 0.57% of the portfolio, ranked #30.

Fairscale Capital first reported a position in JNJ in Q2 2024 and has held it in 9 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Fairscale Capital held 3,779 shares of Johnson & Johnson worth $960K as of Q2 2026.
  • Fairscale Capital sold 22 Johnson & Johnson shares in Q2 2026, an estimated $5.13K.
  • Johnson & Johnson made up 0.57% of Fairscale Capital's portfolio in Q2 2026, its #30 holding.
  • Fairscale Capital first reported a position in Johnson & Johnson in Q2 2024 and has held it in 9 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.